Definition:
The Digestives and Intestinal Remedies market comprises over-the-counter natural and synthetic digestive agents and remedies against gastrointestinal complaints. Digestives include preparations in the form of pills, powder, capsules, liquids, solutions, suspensions, drops and suppositories. Not included are prescription medicines, preparations that are against the state law or are not explicit digestive drugs (e.g. painkillers). Among the top-selling digestives are Perenterol, Iberogast, Dulcolax and Buscopan Plus. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.
Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.
Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.
Most recent update: Mar 2024
The Digestives & Intestinal Remedies market in Serbia has been experiencing steady growth in recent years, driven by changing customer preferences and an increasing awareness of digestive health. Customer preferences in the Digestives & Intestinal Remedies market in Serbia have shifted towards natural and herbal remedies. Consumers are becoming more conscious of the ingredients in the products they consume and are seeking out options that are perceived as healthier and more gentle on the digestive system. This trend is in line with the global shift towards natural and organic products, as consumers become more health-conscious and seek out alternatives to traditional pharmaceutical remedies. Trends in the market indicate a growing demand for probiotics and digestive enzymes in Serbia. Probiotics are live bacteria and yeasts that are beneficial for digestive health, while digestive enzymes help break down food and aid in digestion. These products are gaining popularity as consumers look for ways to improve their gut health and alleviate digestive issues such as bloating, indigestion, and irritable bowel syndrome. The increasing availability of these products in pharmacies and health food stores is further driving their adoption in the market. Local special circumstances in Serbia, such as a traditional diet rich in fermented foods, may contribute to the growing demand for Digestives & Intestinal Remedies. Fermented foods like yogurt, sauerkraut, and kefir are known to contain probiotics that promote gut health. The cultural familiarity with these foods may make consumers more receptive to the idea of incorporating probiotic supplements into their daily routine. Additionally, the prevalence of digestive issues among the population may also be a contributing factor to the increased demand for digestive remedies. Underlying macroeconomic factors, such as an improving economy and increasing disposable income, are also driving the growth of the Digestives & Intestinal Remedies market in Serbia. As people have more money to spend on healthcare and wellness products, they are more likely to invest in products that promote digestive health. The growing middle class in Serbia is becoming more health-conscious and willing to spend on preventive healthcare, leading to increased demand for Digestives & Intestinal Remedies. In conclusion, the Digestives & Intestinal Remedies market in Serbia is experiencing growth due to changing customer preferences towards natural and herbal remedies, a growing demand for probiotics and digestive enzymes, local cultural factors, and underlying macroeconomic factors such as an improving economy and increasing disposable income.
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights